Search Results - "Pettit, Kristen Marie"

Ras Activity Is Significantly Elevated in Patients with Primary Myelofibrosis and Is Agnostic to the Presence of RAS and JAK pathwaymutations by Reynolds, Samuel B, Kandarpa, Malathi, Pettit, Kristen Marie, Ribick, Mark, Talpaz, Moshe, Li, Qing

“…Myelofibrosis (MF) is a myeloproliferative stem cell disorder arising from various clonal mutations in early myeloid-committed hematopoietic progenitor cells…”
Get full text

Durability of Hematocrit Control in Polycythemia Vera with the First-in-Class Hepcidin Mimetic Rusfertide: Two-Year Follow up Results from the Revive Study by Ritchie, Ellen K., Pettit, Kristen Marie, Kuykendall, Andrew T., Kremyanskaya, Marina, Pemmaraju, Naveen, Khanna, Sarita, Molina, Arturo, Gupta, Suneel

“…Background: Polycythemia vera (PV) is a myeloproliferative neoplasm associated with uncontrolled erythrocytosis, systemic symptoms, and an increased risk of…”
Get full text

MRI Reliably Captures Bone Marrow Metrics in Myelofibrosis by Robison, Tanner, Levinson, Annabel, Lee, Winston, Pettit, Kristen Marie, Malyarenko, Dariya, Johnson, Timothy D, Chenevert, Thomas, Ross, Brian, Talpaz, Moshe, Luker, Gary

“…Purpose Biopsy remains the clinical standard for evaluating bone marrow of patients with myelofibrosis (MF). However, randomly sampling a small volume of bone…”
Get full text

A Phase 2 Study of Fedratinib in Patients with MDS/MPN and Chronic Neutrophilic Leukemia by Kuykendall, Andrew T., Pettit, Kristen Marie, Singh, Abhay, Jain, Tania, Sallman, David A, Mo, Qianxing, Lovette, Quan, Zhang, Ling, Chan, Onyee, Walker, Alison R., Xie, Zhuoer, Lancet, Jeffrey, Balasis, Maria, Yun, Seongseok, Padron, Eric, Komrokji, Rami S.

“…Introduction MDS/MPNs are clinically and molecularly complex diseases that exhibit proliferative symptoms and aggressive clinical courses. Evaluation of…”
Get full text

A Phase 1 Study of Avapritinib in Combination with Decitabine in Patients with Systemic Mastocytosis with an Associated Hematologic Neoplasm by Kuykendall, Andrew T., Ball, Somedeb, Gotlib, Jason, Arana Yi, Cecilia Y., Tashi, Tsewang, Rampal, Raajit K., DeAngelo, Daniel J., Volpe, Virginia O., Pettit, Kristen Marie, Komrokji, Rami S., Padron, Eric

“…Background and Rationale: Systemic mastocytosis (SM) is a clonal hematologic neoplasm characterized by abnormal accumulation of mast cells which can lead to…”
Get full text

Outcomes of Patients with Accelerated/Blast-Phase MPNs That Received Allogeneic Stem-Cell Transplant in the Current Era of Myeloid Therapies by Patel, Anand Ashwin, Yoon, James J., Johnston, Hannah, Davidson, Marta Beata, Viswabandya, Auro, Shallis, Rory M., Chen, Evan C., Burkart, Madelyn, Oh, Timothy S., Iyer, Sunil G., Madarang, Ellen, Muthiah, Chandrasekar, Dean, Raven, Kassner, Joshua, Rampal, Raajit K., Guru Murthy, Guru Subramanian, Bradley, Terrence, Abaza, Yasmin, Garcia, Jacqueline S., Gupta, Vikas, Pettit, Kristen Marie, Cursio, John, Odenike, Olatoyosi

“…Background Patients (pts) with Philadelphia chromosome-negative (Ph-neg) myeloproliferative neoplasms (MPNs) that progress to an accelerated phase (AP) or…”
Get full text

Bayesian network meta-analysis (NMA) of complete remission without or with incomplete hematologic recovery (CR/CRi) to CPX-351, FLAG, and standard 7+3 (7+3) chemotherapy in the treatment of newly diagnosed secondary acute myeloid leukemia (sAML) by Oh, Mok, Marini, Bernard, Perissinotti, Anthony, Benitez, Lydia, Burke, Patrick William, Bixby, Dale L., Pettit, Kristen Marie, Abraham, Ivo, McBride, Ali

“…Abstract only e18514 Background: Patients (pts) sAML have poor outcomes (CR/CRi= 25-35%) with standard 7+3 induction chemotherapy (7+3). CPX-351 (liposomal…”
Get full text